Data on types of treatment, efficacy and adverse events were obtained from MEDLINE, the Cochrane database and abstracts from national meetings.Population:Six randomized, controlled trials with a total of 1,756 patients.Main Results:Sustained virologic response was greater for patients treated with pegylated interferon + ribavirin compared with patients treated with interferon + ribavirin or pegyla